Boston Scientific Wins FDA Approval of Stent for Smaller Blood Vessels

Luke Timmerman9/25/08

Boston Scientific said today it has won clearance from the FDA to market the Taxus Express2 Atom Stent System. The new device, which props open clogged heart arteries, emits a small dose of a chemotherapy drug designed to minimize scarring around the implant. It is the only device approved for vessels as small as 2.25 millimeters in diameter, the Natick, MA-based company (NYSE: BSX) said in a statement. The company plans to start selling the device immediately.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.